These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31276956)

  • 1. Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer.
    Nuzzo S; Catuogno S; Capuozzo M; Fiorelli A; Swiderski P; Boccella S; de Nigris F; Esposito CL
    Mol Ther Nucleic Acids; 2019 Sep; 17():256-263. PubMed ID: 31276956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.
    Russo V; Paciocco A; Affinito A; Roscigno G; Fiore D; Palma F; Galasso M; Volinia S; Fiorelli A; Esposito CL; Nuzzo S; Inghirami G; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2018 Dec; 13():334-346. PubMed ID: 30340138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression.
    Quirico L; Orso F; Esposito CL; Bertone S; Coppo R; Conti L; Catuogno S; Cavallo F; de Franciscis V; Taverna D
    Int J Biol Sci; 2020; 16(7):1238-1251. PubMed ID: 32174798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL.
    Iaboni M; Russo V; Fontanella R; Roscigno G; Fiore D; Donnarumma E; Esposito CL; Quintavalle C; Giangrande PH; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2016 Mar; 5(3):e289. PubMed ID: 27111415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Axl with an high-affinity inhibitory aptamer.
    Cerchia L; Esposito CL; Camorani S; Rienzo A; Stasio L; Insabato L; Affuso A; de Franciscis V
    Mol Ther; 2012 Dec; 20(12):2291-303. PubMed ID: 22910292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation.
    Stahlhut C; Slack FJ
    Cell Cycle; 2015; 14(13):2171-80. PubMed ID: 25714397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo.
    Jiang Q; Yuan Y; Gong Y; Luo X; Su X; Hu X; Zhu W
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2951-2967. PubMed ID: 31654121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
    Sun X; Xu M; Liu H; Ming K
    Mol Med Rep; 2017 Sep; 16(3):3557-3564. PubMed ID: 28714014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.
    Lee HY; Mohammed KA; Kaye F; Sharma P; Moudgil BM; Clapp WL; Nasreen N
    Int J Nanomedicine; 2013; 8():4481-94. PubMed ID: 24293999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells.
    Wang H; Zhao X; Guo C; Ren D; Zhao Y; Xiao W; Jiao W
    PLoS One; 2015; 10(9):e0139136. PubMed ID: 26406332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3.
    Esposito CL; Nuzzo S; Ibba ML; Ricci-Vitiani L; Pallini R; Condorelli G; Catuogno S; de Franciscis V
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel.
    Liu R; Liu X; Zheng Y; Gu J; Xiong S; Jiang P; Jiang X; Huang E; Yang Y; Ge D; Chu Y
    Oncol Lett; 2014 Nov; 8(5):2193-2200. PubMed ID: 25289099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
    He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
    J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Oligonucleotide Aptamers for NSCLC Targeting.
    Rotoli D; Santana-Viera L; Ibba ML; Esposito CL; Catuogno S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells.
    Chen C; Zhao Z; Liu Y; Mu D
    Oncol Lett; 2015 Mar; 9(3):1128-1134. PubMed ID: 25663868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.
    Wang J; Shi C; Wang J; Cao L; Zhong L; Wang D
    Oncol Lett; 2017 May; 13(5):3247-3252. PubMed ID: 28521431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p.
    Zeng Q; Dai Y; Duan C; Zeng R; Zeng Q; Wei C
    BMC Pulm Med; 2020 Jul; 20(1):185. PubMed ID: 32615948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4.
    Chen T; Gao F; Feng S; Yang T; Chen M
    Oncol Rep; 2015 Jul; 34(1):461-8. PubMed ID: 25976502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.